FIELD: medicine.
SUBSTANCE: after establishing a diagnosis of delirium associating dementia and a diagnosis of hallucinosis related to a cerebral new growth in the acute postoperative period, the following therapeutic regimen is prescribed: Sonapax 60 mg/day + Melaxen 18 mg/day (9 mg at 2 p.m. and 9 mg for the night) for three days, then a dose of Sonapax is gradually decreased to 30 mg/day. The therapy is continued for a week after reducing the symptoms.
EFFECT: effective treatment of the mental disorders in the neurooncological patients by the effective combination of low doses of the neuroleptic and the preparation of melatonin.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTING ACUTE MENTAL DISORDERS IN PATIENTS AFTER HEART TRANSPLANTATION | 2016 |
|
RU2634377C1 |
| METHOD FOR ADJUVANT CHEMOTHERAPY OF MALIGNANT CEREBRAL GLIOMAS | 2010 |
|
RU2466739C2 |
| METHOD OF TREATMENT IN ALCOHOLIC DELIRIUM | 2005 |
|
RU2300376C2 |
| METHOD OF ALCOHOLIC ABSTINENCE SYNDROME REDUCTION | 2006 |
|
RU2327474C1 |
| METHOD FOR TREATING CHRONIC AUDITORY THERAPY-RESISTANT HALLUCINOSIS | 2002 |
|
RU2219936C2 |
| METHOD OF TREATMENT OF INTOXICATION PSYCHOSES BY TYPE OF DELIORIOUS CONFUSION | 2017 |
|
RU2676698C1 |
| METHOD FOR DETERMINING INFUSION THERAPY EXTENT IN ALCOHOLIC ENCEPHALOPATHY | 2014 |
|
RU2547245C1 |
| CONSTITUTIONAL APPROACH TO CUPPING OFF PSYCHOGENIC NONPSYCHOTIC-LEVEL PSYCHOPATHOLOGIC SYNDROMES IN TERRORISM VICTIMS AND HOSTAGES | 1999 |
|
RU2161968C1 |
| METHOD OF PREDICTING SURVIVAL POTENTIAL OF PATIENTS WITH MALIGNANT GLIOMAS | 2010 |
|
RU2439577C2 |
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
